GridAI Technologies Corp. (GRDX)
Nasdaq · Healthcare · Biotechnology
$3.83+0.52%as of Oct 6, 2026, 1:35 AM ET
- Market cap
- $27.3M
- 52-week range
- $1.87 – $6.93
- 52-week change
- −7.52%
- EPS (trailing)
- −$5.65
Fiscal year to Dec 2025
- Revenue
- $36K
- Net income
- −$6.4M
- Operating margin
- −19539.9%
- Diluted EPS
- −$4.16
From the company’s annual report on SEC EDGAR.
About GridAI Technologies Corp.
GridAI Technologies Corp., together with its subsidiaries, designs and develops an artificial intelligence (AI)-driven software and device platform that enables utilities, retailers, and large power users to manage load and distributed energy resources. It also develops Adrulipase, a recombinant lipase enzyme program for the treatment of exocrine pancreatic insufficiency. The company is based in Edinburgh, United Kingdom.
Headquarters: Edinburgh, United Kingdom · grid-ai.com